Stay updated on PXL770 Efficacy in NAFLD: 12-Week Clinical Trial
Sign up to get notified when there's something new on the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page.

Latest updates to the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now includes revision 3.5.0 and removes revision 3.4.3. This reflects an updated version history for the study record.SummaryDifference0.1%

- Check21 days agoChange DetectedA new revision entry v3.4.3 was added to the record history and the previous v3.4.2 revision was removed.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.0 was removed in the history view, a UI/version metadata update rather than a substantive change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now includes a glossary toggle and a color-coded legend for record changes. The footer revision label has been updated to v3.4.0.SummaryDifference1%

- Check78 days agoChange DetectedA new revision entry v3.3.4 was added to the history, replacing v3.3.3. No study data or results are changed in this view.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision label 'Revision: v3.3.3' is now shown. References to 'HHS Vulnerability Disclosure' and the prior 'Revision: v3.3.2' have been removed.SummaryDifference0.2%

Stay in the know with updates to PXL770 Efficacy in NAFLD: 12-Week Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PXL770 Efficacy in NAFLD: 12-Week Clinical Trial page.